Publikacje w czasopismach z IF w 2012 (IF>1)

1. Amar L, Fassnacht M, Gimenez-Roqueplo AP, Januszewicz A, Prejbisz A, Timmers H, Plouin PF.: Long-term Postoperative Follow-up in Patients with Apparently Benign Pheochromocytoma and Paraganglioma. Horm Metab Res. 2012; 44(5): 385-9. (IF=2.414; MNiSW=20).
   
   
2. Banaszewski M, Stepinska J.: Right heart perforation by pacemaker leads. Arch Med Sci. 2012; 8(1): 11-13. (IF=1.199; MNiSW=20).
   
   
3. Bandosz P, O'Flaherty M, Drygas W, Rutkowski M, Koziarek J, Wyrzykowski B, Bennett K, Zdrojewski T, Capewell S.: Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. BMJ. 2012; 344d8136. (IF=13.471; MNiSW=32).
   
   
4. Borowiec A, Dabrowski R, Wozniak J, Jasek S, Chwyczko T, Kowalik I, Musiej-Nowakowska E, Szwed H.: Cardiovascular assessment of asymptomatic patients with juvenile-onset localized and systemic scleroderma: 10 years prospective observation. Scand J Rheumatol. 2012; 41(1): 33-38. (IF=2.594; MNiSW=27).
   
   
5. Claessen BE, Stone GW, Mehran R, Witzenbichler B, Brodie BR, Wohrle J, Witkowski A, Guagliumi G, Zmudka K, Henriques JP, Tijssen JG, Sanidas EA, Chantziara V, Hakim D, Leon S, Xu K, Dangas GD.: Relationship between biomarkers and subsequent clinical and angiographic restenosis after paclitaxel-eluting stents for treatment of STEMI: a HORIZONS-AMI substudy. J Thromb Thrombolysis. 2012; (IF=1.539; MNiSW=20).
   
   
6. Conraads VM, Deaton C, Piotrowicz E, Santaularia N, Tierney S, Piepoli MF, Pieske B, Schmid JP, Dickstein K, Ponikowski PP, Jaarsma T.: Adherence of heart failure patients to exercise: barriers and possible solutions: A position statement of the Study Group on Exercise Training in Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2012; 14(5): 451-8; (IF=4.512; MNiSW=32).
   
   
7. Derejko M, Derejko P, Przybylski A, Niewiadomska M, Antczak J, Banach M, Rakowicz M, Szumowski L, Walczak F.: Safety of nerve conduction studies in patients with implantable cardioverter-defibrillators. Clin Neurophysiol. 2011; (IF=2.786; MNiSW=32).
   
   
8. Derejko P, Orczykowski M, Szumowski LJ, Walczak F.: Recurrence of RVOT PVCs with a Marked Shift of Its Exit Point. Gradual Elimination of Arrhythmogenic Focus by Multisite Approach. Pacing Clin Electrophysiol. 2012; 35(1): e6-9. (IF=1.353; MNiSW=27).
   
   
9. Derejko P, Szumowski LJ, Sanders P, Krupa W, Bodalski R, Orczykowski M, Urbanek P, Zakrzewska J, Lim HS, Lau DH, Kusnierz J, Walczak F.: Atrial Fibrillation in Patients with Wolff-Parkinson-White Syndrome:: Role of Pulmonary Veins. J Cardiovasc Electrophysiol. 2012;23(3): 280-6. (IF=3.293; MNiSW=32)
   
   
10. Dubner S, Auricchio A, Steinberg JS, Vardas P, Stone P, Brugada J, Piotrowicz R, Hayes DL, Kirchhof P, Breithardt G, Zareba W, Schuger C, Aktas MK, Chudzik M, Mittal S, Varma N.: ISHNE/EHRA Expert Consensus on Remote Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs). Ann Noninvasive Electrocardiol. 2012; 17(1): 36-56. (IF=1.487; MNiSW=20).
    
    
11. Dubner S, Auricchio A, Steinberg JS, Vardas P, Stone P, Brugada J, Piotrowicz R, Hayes DL, Kirchhof P, Breithardt G, Zareba W, Schuger C, Aktas MK, Chudzik M, Mittal S, Varma N, Document reviewers:, Israel C, Padeletti L, Brignole M.: ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace. 2012; 14(2): 278-93. (IF=1.842; MNiSW=20).
    
    
12. Gieraltowski J, Zebrowski JJ, Baranowski R.: Multiscale multifractal analysis of heart rate variability recordings with a large number of occurrences of arrhythmia. Phys Rev E Stat Nonlin Soft Matter Phys. 2012; 85(2-1): 021915. (IF=2.352; MNiSW=32)
    
    
13. Grabowski M, Hryniewiecki T, Stepinska J.: Novel markers of cerebral embolism in the course of infective endocarditis. Int J Cardiol. 2012; 154(1): 90-92. (IF=6.802; MNiSW=27).
    
    
14. Grabowski T, Jaroszewski JJ, Piotrowski W, Feder M.: Qualitative structure residue relationship analysis in the determination of the maximum residue limit of veterinary drugs. Chemosphere. 2012; 87(4): 312-8.(IF=3.155; MNiSW=32).
    
    
15. Jaworska-Wilczynska M, Abramczuk E, Hryniewiecki T.: Postcardiac injury syndrome. Part II. Med Sci Monit. 2012; 18(2): CQ1-3. (IF=1.699; MNiSW=20).
    
    
16. Kepka C, Opolski MP, Juraszynski Z, Kruk M, Pregowski J, Pracon R, Dyk W, Demkow M, Witkowski A, Ruzyllo W.: Computed Tomography to Predict Surgical Revascularization of a Left Anterior Descending Artery Occlusion Incompletely Visualized by Conventional Angiography. J Thorac Imaging. 2012; 27(3): 184-93;(IF=1.207; MNiSW=20).
    
    
17. Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kaab S, Schotten U, Wegscheider K, Boriani G, Brandes A, Ezekowitz M, Diener H, Haegeli L, Heidbuchel H, Lane D, Mont L, Willems S, Dorian P, Aunes-Jansson M, Blomstrom-Lundqvist C, Borentain M, Breitenstein S, Brueckmann M, Cater N, Clemens A, Dobrev D, Dubner S, Edvardsson NG, Friberg L, Goette A, Gulizia M, Hatala R, Horwood J, Szumowski L, Kappenberger L, Kautzner J, Leute A, Lobban T, Meyer R, Millerhagen J, Morgan J, Muenzel F, Nabauer M, Baertels C, Oeff M, Paar D, Polifka J, Ravens U, Rosin L, Stegink W, Steinbeck G, Vardas P, Vincent A, Walter M, Breithardt G, Camm AJ.: Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace. 2012; 14(1): 8-27. (IF=1.842; MNiSW=20).
    
    
18. Konopka A, Szperl M, Piotrowski W, Stepinska J.: Polymorphisms of angiotensin II type 1 receptor gene and those of angiotensinogen point at culprit artery in ST-segment elevation myocardial infarction. Gene. 2012; 500(1): 148-50. (IF=2.266; MNiSW=27).
    
    
19. Kryczka K, Dzielinska Z, Przybylski A, Szczudlik J, Dangel J, Konka M, Czajkowski K, Rozanski J, Bilinska ZT, Demkow M.: Therapeutic challenges and management of heart failure during pregnancy (part I). Med Sci Monit. 2012; 18(5): CQ5-7. (IF=1.699; MNiSW=20)
    
    
20. Kwasniewska M, Pikala M, Kaczmarczyk-Chalas K, Piwonska A, Tykarski A, Kozakiewicz K, Pajak A, Zdrojewski T, Drygas W.: Smoking status, the menopausal transition, and metabolic syndrome in women. Menopause. 2012; 19(2): 194-201. (IF=3.318; MNiSW=32).
    
    
21. Leszek P, Sochanowicz B, Szperl M, Kolsut P, Brzoska K, Piotrowski W, Rywik TM, Danko B, Polkowska-Motrenko H, Rozanski JM, Kruszewski M.: Myocardial iron homeostasis in advanced chronic heart failure patients. Int J Cardiol. 2011; (IF=6.802; MNiSW=27).
    
    
22. Lubiszewska B, Kruk M, Broda G, Ksiezycka E, Piotrowski W, Kurjata P, Zielinski T, Ploski R.: The impact of early menopause on risk of coronary artery disease (PREmature Coronary Artery Disease In Women - PRECADIW case-control study). Eur J Prev Cardiolog. 2012; 19(1): 95-101. (IF=2.638; MNiSW=27).
    
    
23. Malek LA, Spiewak M, Klopotowski M, Misko J, Ruzyllo W, Witkowski A.: The size does not matter - The presence of microvascular obstruction but not its extent corresponds to larger infarct size in reperfused STEMI. Eur J Radiol. 2011; (IF=2.941; MNiSW=27).
    
    
24. Malek LA, Spiewak M, Klopotowski M, Petryka J, Mazurkiewicz L, Kruk M, Kepka C, Misko J, Ruzyllo W, Witkowski A.: Influence of left ventricular hypertrophy on infarct size and left ventricular ejection fraction in ST-elevation myocardial infarction. Eur J Radiol. 2012; 81(3): e 177-81; (IF=2941; MNiSW=27).
    
    
25. Menne J, Izzo JL,Jr, Ito S, Januszewicz A, Katayama S, Chatzykirkou C, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, Haller H, for the ROADMAP investigators.: Prevention of microalbuminuria in patients with type 2 diabetes and hypertension. J Hypertens. 2012; 30(4): 811-818. (IF=3.980; MNiSW=32).
    
    
26. Mills JS, Mahaffey KW, Lokhnygina Y, Nicolau JC, Ruzyllo W, Adams PX, Todaro TG, Armstrong PW, Granger CB, for the CARDINAL investigators.: Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction. Coron Artery Dis. 2012; 23(2): 118-125. (IF=1.665; MNiSW=20).
    
    
27. Opolski MP, Kepka C, Achenbach S, Juraszynski Z, Pregowski J, Kruk M, Niewada M, Jakubczyk M, Teresinska A, Chojnowska L, Bilinska ZT, Dzielinska Z, Demkow M, Ruzyllo W, Chmielak Z, Witkowski A.: Coronary Computed Tomographic Angiography for Prediction of Procedural and Intermediate Outcome of Bypass Grafting to Left Anterior Descending Artery Occlusion With Failed Visualization on Conventional Angiography. Am J Cardiol. 2012; (IF=3.681; MNiSW=32).
    
    
28. Opolski MP, Kepka C, Witkowski A.: CT evaluation of vulnerable plaque: noninvasive fortune-telling? Int J Cardiovasc Imaging. 2011; (IF=2.539; MNiSW=20).
    
    
29. Orczykowski M, Walczak F, Derejko P, Bodalski R, Urbanek P, Zakrzewska-Koperska J, Przybylski A, Kępski R, Jedynak Z, Maryniak A, Miszczak-Knecht M, Bieganowska K, Szufladowicza E, Biederman A, Bilińska M, Szumowski L.: Ventricular fibrillation risk factors in over one thousand patients with accessory pathways. Int J Cardiol. 2012 Feb 21; [Epub ahead of print](IF=6.802;MNiSW=27).
    
    
30. Petryka J, Misko J, Przybylski A, Spiewak M, Malek LA, Werys K, Mazurkiewicz L, Gepner K, Croisille P, Demkow M, Ruzyllo W.: Magnetic resonance imaging assessment of intraventricular dyssynchrony and delayed enhancement as predictors of response to cardiac resynchronization therapy in patients with heart failure of ischaemic and non-ischaemic etiologies. Eur J Radiol. 2011; (IF=2.941; MNiSW=27).
    
    
31. Pollak A, Mueller-Malesinska M, Lechowicz U, Skorka A, Korniszewski L, Sobczyk-Kopciol A, Waskiewicz A, Broda G, Iwanicka-Pronicka K, Oldak M, Skarzynski H, Ploski R.: MTHFR 677T Is a Strong Determinant of the Degree of Hearing Loss Among Polish Males with Postlingual Sensorineural Hearing Impairment. DNA Cell Biol. 2012; (IF=2.159; MNiSW=20).
    
    
32. Pregowski J, Kaczmarska E, Kepka C, Kruk M, Dzielinska Z, Demkow M, Witkowski A.: Single Coronary Artery With Anomalous Origin From the Pulmonary Trunk: Congenital Lack of Coronary Arteries Originating From the Aortic Bulb. J Thorac Imaging. 2012; 27(3): W44-5. (IF=1.207; MNiSW=20).
    
    
33. Reynolds HR, Forman SA, Tamis-Holland JE, Steg PG, Mark DB, Pearte CA, Carvalho AC, Sopko G, Liu L, Lamas GA, Kruk M, Loboz-Grudzien K, Ruzyllo W, Hochman JS.: Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: Analysis of the Occluded Artery Trial (OAT). Am Heart J. 2012; 163(3): 462-469. (IF=5.052; MNiSW=32).
    
    
34. Rosenhek R, Iung B, Tornos P, Antunes MJ, Prendergast BD, Otto CM, Kappetein AP, Stepinska J, Kaden JJ, Naber CK, Acarturk E, Gohlke-Barwolf C.: ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J. 2012; 33(7): 822-8.(IF=10.052; MNiSW=32).
    
    
35. Rybicka J, Kowalski M, Rozanski J, Hoffman P.: Successful reoperation of the valveless calcified right atrium to right ventricle conduit in an adult patient with tricuspid atresia after Fontan procedure. Eur J Cardiothorac Surg. 2012; 41(3): e 18-20; (IF=2.293; MNiSW=32).
    
    
36. Saj M, Dabrowski R, Labib S, Jankowska A, Szperl M, Broda G, Szwed H, Tesson F, Bilinska ZT, Ploski R.: Variants of the Lamin A/C (LMNA) Gene in Non-Valvular Atrial Fibrillation Patients: A Possible Pathogenic Role of the Thr528Met Mutation. Mol Diagn Ther. 2012; (IF=2.561; MNiSW=20).
    
    
37. Sorensen K, Broucke SV, Fullam J, Doyle G, Pelikan J, Slonska Z, Brand H, Hls-Eu Consortium EH.: Health literacy and public health: A systematic review and integration of definitions and models. BMC Public Health. 2012; 12(1): 80. (IF=2.364; MNiSW=27).
    
    
38. Szymanski P, Klisiewicz A, Spiewak M, Szumowski L, Walczak F, Hoffman P.: Left dominant arrhythmogenic cardiomyopathy - A newly defined clinical entity. Int J Cardiol. 2012; 156(3): e.60-1. (IF=6.802; MNiSW=27).
    
    
39. Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW, TRACER Investigators.: Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med. 2012; 366(1): 20-33. (IF=53.486; MNiSW=40).
    
    
40. Zatorska K, Orlowska-Baranowska E, Abramczuk E, Kusmierczyk M, Greszata L, Grabowski M, Stepinska J, Baran B, Windyga J.: Short and long-term management of haemophilia A patient requiring heart valve surgery. Haemophilia. 2012; (IF=2.364; MNiSW=27)